These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18641)

  • 1. Inhibition by beta-carbolines of monoamine uptake into a synaptosomal preparation: structure-activity relationships.
    Buckholtz NS; Boggan WO
    Life Sci; 1977 Jun; 20(12):2093-9. PubMed ID: 18641
    [No Abstract]   [Full Text] [Related]  

  • 2. beta-Carbolines: a tool for investigating structure-activity relationships of the high-affinity uptake of serotonin, noradrenaline, dopamine, GABA and choline into a synaptosome-rich fraction of various regions from rat brain.
    Rommelspacher H; Strauss SM; Rehse K
    J Neurochem; 1978 Jun; 30(6):1573-8. PubMed ID: 670999
    [No Abstract]   [Full Text] [Related]  

  • 3. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
    Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurobiology of tetrahydro-beta-carbolines.
    Buckholtz NS
    Life Sci; 1980 Sep; 27(11):893-903. PubMed ID: 6107810
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of monoamine uptake in synaptosomes by tetrahydroharmane and tetrahydroisoquinoline compounds.
    Tuomisto L; Tuomisto J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(4):371-80. PubMed ID: 4150087
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of synaptosomal neurotransmitter uptake by hallucinogens.
    Whipple MR; Reinecke MG; Gage FH
    J Neurochem; 1983 Apr; 40(4):1185-8. PubMed ID: 6131933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition site.
    Langer SZ; Raisman R; Tahraoui L; Scatton B; Niddam R; Lee CR; Claustre Y
    Eur J Pharmacol; 1984 Feb; 98(1):153-4. PubMed ID: 6325207
    [No Abstract]   [Full Text] [Related]  

  • 8. The inhibitory action of ketamine HC1 on [3H]5-hydroxytryptamine accumulation by rat brain synaptosomal-rich fractions: comparison with [3H]catecholamine and [3H]gamma-aminobutyric acid uptake.
    Azzaro AJ; Smith DJ
    Neuropharmacology; 1977 May; 16(5):349-56. PubMed ID: 17078
    [No Abstract]   [Full Text] [Related]  

  • 9. Trimethyltin inhibits uptake of neurotransmitters into mouse forebrain synaptosomes.
    Doctor SV; Costa LG; Kendall DA; Murphy SD
    Toxicology; 1982; 25(2-3):213-21. PubMed ID: 6130643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity.
    Buckholtz NS; Boggan WO
    Biochem Pharmacol; 1977 Nov; 26(21):1991-6. PubMed ID: 921812
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the reuptake of serotonin by tryptoline.
    Rommelspacher H; Bade P; Coper H; Kossmehl G
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):93-5. PubMed ID: 934360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptoline inhibition of serotonin uptake in rat forebrain homogenates.
    Keller KJ; Elliott GR; Holman RB; Vernikos-Danellis J; Barchas JD
    J Pharmacol Exp Ther; 1976 Sep; 198(3):619-25. PubMed ID: 978463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter metabolism in rat brain synaptosomes: effect of anoxia and pH.
    Pastuszko A; Wilson DF; Erecińska M
    J Neurochem; 1982 Jun; 38(6):1657-67. PubMed ID: 6122721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformation study of the inhibition of monoamine uptake in rat brain synaptosomes.
    Tuomisto J; Tuomisto L; Smissman EE
    Ann Med Exp Biol Fenn; 1973; 51(2):51-8. PubMed ID: 4756095
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of 4-(3-indolyl-alkyl)piperidine derivatives on uptake and release of noradrenaline, dopamine and 5-hydroxytryptamine in rat brain synaptosomes, rat heart and human blood platelets.
    Le Fur G; Uzan A
    Biochem Pharmacol; 1977 Mar; 26(6):497-503. PubMed ID: 849346
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in hypothalamic neurotransmitter uptake following pinealectomy, superior cervical ganglionectomy or melatonin administration to rats.
    Cardinali DP
    Neuroendocrinology; 1975; 19(1):91-5. PubMed ID: 1692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topography of synaptosomal high affinity uptake systems.
    Wang YJ; Gurd JW; Mahler HR
    Life Sci; 1975 Sep; 17(5):725-33. PubMed ID: 1614
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets.
    Airaksinen MM; Svensk H; Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):308-13. PubMed ID: 7368950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tetrahydro-beta-carbolines on monoamine oxidase and serotonin uptake in mouse brain.
    Buckholtz NS; Boggan WO
    Biochem Pharmacol; 1976 Oct; 25(20):2319-31. PubMed ID: 985563
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium-dependent release of radiolabeled catecholamines and serotonin from rat brain synaptosomes in a superfusion system.
    Mulder AH; van den Berg WB; Stoof JC
    Brain Res; 1975 Dec; 99(2):419-24. PubMed ID: 241465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.